The most commonly proposed mechanism is that hyperinsulinemia, which results as a compensatory response to the insulin resistance underlying type 2 diabetes, is mitogenic, through activation of the insulin receptor or the insulin-like growth factor-I receptor [2], which in turn stimulates cellular proliferation and inhibits cellular apoptosis [3]. Here, INSR is linked to Hyperinsulinemia.